Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
India Glycols (BOM:500201) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
India Glycols Forward PE Ratio Related Terms
India Glycols Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for India Glycols's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
India Glycols Forward PE Ratio Chart
India Glycols Annual Data
Trend
2025-03
Forward PE Ratio
9.55
India Glycols Quarterly Data
2024-12
2025-03
2025-06
2025-09
2026-06
Forward PE Ratio
11.22
9.55
17.58
7.20
8.23
BOM:500201 vs DOW: Forward PE Ratio Comparison
For the Chemicals subindustry, India Glycols's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols Forward PE Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where India Glycols's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
India Glycols (BOM:500201) has a Forward PE Ratio of 9.37 as of Sep. 02, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on India Glycols and its competitors. According to the industry distribution chart, India Glycols ranks #107 out of 663 companies in the Chemicals industry, placing it in the top 16.1%.
Is India Glycols' Forward PE Ratio too high?
India Glycols' current Forward PE Ratio is 9.37. The Chemicals industry median Forward PE Ratio is 16.06. India Glycols' value of 9.37 is 41.7% below this industry median. Based on the distribution chart, India Glycols ranks #107 out of 663 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Forward PE Ratio compare to DOW?
According to the Chemicals industry distribution chart, India Glycols ranks #107 out of 663 companies for Forward PE Ratio. This places India Glycols in the top 16% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 16.06. India Glycols' value of 9.37 is 41.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Chemicals company?
The median Forward PE Ratio among Chemicals companies is 16.06, based on 663 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. India Glycols's current Forward PE Ratio of 9.37 is 41.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on India Glycols and its competitors. For the Chemicals industry, the median Forward PE Ratio is 16.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. India Glycols's current Forward PE Ratio is 9.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹801.01, compared to a current price of ₹1,112.90 — trading 38.9% above its estimated fair value. The current Forward PE Ratio is 9.37 and 41.7% below the Chemicals industry median of 16.06. India Glycols' overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For India Glycols (BOM:500201), the current Forward PE Ratio is 9.37 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is India Glycols (BOM:500201) Overvalued in 2026?
Based on GuruFocus' analysis, India Glycols stock appears to be overvalued.
The current stock price of ₹1,112.90 is trading 38.9% above its estimated GF Value™ of ₹801.01.
GuruFocus considers India Glycols to be Significantly Overvalued.
Key valuation signals for BOM:500201:
Forward PE Ratio: 9.37
GF Value™: ₹801.01 vs. price of ₹1,112.90 (38.9% above fair value)
Industry Position: 41.7% below the Chemicals median (#107 of 663)
No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score
Get the complete analysis for BOM:500201
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500201 has been successfully added to your 
